Opening lecture
Ferran Sanz
IMIM, Universitat Pompeu Fabra
Barcelona (Spain)

Membrane protein targets for medicinal chemistry:
mechanistic insights into cell signaling
from structure-function elucidation
Harel Weinstein
Mount Sinai School of Medicine
New York (USA)

From protein domains to drugs: Natural products as
guiding principles for compound library development
Herbert Waldmann
Max-Planck-Institut fur Molekulare Physiologie,
Dortmund (Germany)

Structure and function of orphan nuclear receptors
Timothy M. Willson
GlaxoSmithKline (USA)

Plenary Lecture of the Nauta Awardee
Structure and activity revisited - Property
spaces and emergent meaning
Bernard Testa
Université de Lausanne
Lausanne (Switzerland)

Molecules to market: The challenges for chemical development
Peter Spargo
Pfizer (UK)

Property-based design:
Getting the ADME properties fast and right
Han van de Waterbeemd
Pfizer Global Research and Development
(UK)

Cannabinoid proteins as therapeutic targets
Alexandros Makriyannis
University of Connecticut
Connecticut (USA)

Molecular pathway of neurodegeneration:
new treatment opportunities
Jörg B. Schulz
University of Tübingen
(Germany)

Gene targeted mice as models for drug discovery
Mariano Barbacid
Centro Nacional de Investigación Oncológica
Madrid (Spain)

Plenary Lecture of the UCB Awardee
Case study: Gleevec - A new treatment modality
for chronic Myelogenous Leukemia
Juerg Zimmermann
Max-Planck-Institut fur Molekulare Physiologie,
Novartis Pharma AG (Switzerland)

Antiviral drug discovery
Chris McGuigan
University of Wales
(UK)

Challenges in drug discovery in the XXIst Century:
Initiatives of the European Union
Alfredo Aguilar
Directorate General Research, European Commission,
Brussels (Belgium)